Russell Investments Group, Ltd. Enanta Pharmaceuticals Inc Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 17,520 shares of ENTA stock, worth $107,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,520

Previous 18,889 7.25%

Holding current value

$107,397

Previous $244,000 25.82%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$10.05 - $16.54 $13,758 - $22,643	-1,369 Reduced 7.25%	17,520 $181,000
Q2 2024 Aug 08, 2024	SELL	$11.43 - $17.02 $3,703 - $5,514	-324 Reduced 1.69%	18,889 $244,000
Q1 2024 May 08, 2024	SELL	$10.08 - $17.46 $48,263 - $83,598	-4,788 Reduced 19.95%	19,213 $335,000
Q4 2023 Feb 05, 2024	SELL	$8.18 - $10.78 $957 - $1,261	-117 Reduced 0.49%	24,001 $225,000
Q3 2023 Nov 13, 2023	SELL	$11.09 - $22.13 $2,373 - $4,735	-214 Reduced 0.88%	24,118 $269,000
Q2 2023 Aug 10, 2023	BUY	$20.68 - $39.85 $4,280 - $8,248	207 Added 0.86%	24,332 $520,000
Q1 2023 May 09, 2023	SELL	$38.82 - $54.59 $17,779 - $25,002	-458 Reduced 1.86%	24,125 $975,000
Q4 2022 Feb 08, 2023	BUY	$40.77 - $53.73 $132,869 - $175,106	3,259 Added 15.28%	24,583 $1.14 Million
Q3 2022 Nov 04, 2022	BUY	$48.29 - $71.27 $29,118 - $42,975	603 Added 2.91%	21,324 $1.11 Million
Q2 2022 Jul 29, 2022	BUY	$38.13 - $76.93 $223,899 - $451,732	5,872 Added 39.54%	20,721 $978,000
Q1 2022 May 05, 2022	SELL	$56.06 - $74.11 $326,044 - $431,023	-5,816 Reduced 28.14%	14,849 $1.06 Million
Q4 2021 Jan 21, 2022	SELL	$60.19 - $97.37 $693,870 - $1.12 Million	-11,528 Reduced 35.81%	20,665 $1.54 Million
Q3 2021 Nov 08, 2021	SELL	$41.02 - $58.65 $61,324 - $87,681	-1,495 Reduced 4.44%	32,193 $1.83 Million
Q2 2021 Aug 04, 2021	SELL	$43.76 - $53.11 $2.31 Million - $2.8 Million	-52,689 Reduced 61.0%	33,688 $1.48 Million
Q1 2021 May 10, 2021	SELL	$41.69 - $54.95 $713,524 - $940,469	-17,115 Reduced 16.54%	86,377 $4.23 Million
Q4 2020 Feb 08, 2021	SELL	$41.16 - $47.47 $172,954 - $199,468	-4,202 Reduced 3.9%	103,492 $4.34 Million
Q3 2020 Nov 09, 2020	SELL	$43.36 - $53.53 $1.26 Million - $1.55 Million	-28,972 Reduced 21.2%	107,694 $4.91 Million
Q2 2020 Aug 05, 2020	BUY	$46.37 - $57.58 $178,060 - $221,107	3,840 Added 2.89%	136,666 $6.82 Million
Q1 2020 May 06, 2020	BUY	$40.22 - $62.0 $1.12 Million - $1.73 Million	27,954 Added 26.66%	132,826 $6.81 Million
Q4 2019 Jan 29, 2020	BUY	$57.95 - $66.61 $437,174 - $502,505	7,544 Added 7.75%	104,872 $6.47 Million
Q3 2019 Nov 01, 2019	BUY	$60.08 - $88.17 $470,005 - $689,753	7,823 Added 8.74%	97,328 $5.86 Million
Q2 2019 Aug 09, 2019	BUY	$81.3 - $97.35 $153,657 - $183,991	1,890 Added 2.16%	89,505 $7.52 Million
Q1 2019 May 13, 2019	SELL	$69.08 - $105.66 $92,014 - $140,739	-1,332 Reduced 1.5%	87,615 $8.35 Million
Q4 2018 Feb 11, 2019	SELL	$65.41 - $84.65 $180,335 - $233,380	-2,757 Reduced 3.01%	88,947 $6.25 Million
Q3 2018 Oct 26, 2018	BUY	$85.46 - $126.37 $696,669 - $1.03 Million	8,152 Added 9.76%	91,704 $8.06 Million
Q2 2018 Aug 08, 2018	BUY	$81.85 - $120.51 $3.27 Million - $4.81 Million	39,908 Added 91.44%	83,552 $9.5 Million
Q1 2018 May 11, 2018	BUY	$57.91 - $92.15 $1.35 Million - $2.15 Million	23,305 Added 114.58%	43,644 $3.53 Million
Q4 2017 Feb 06, 2018	BUY	$45.65 - $59.37 $870,499 - $1.13 Million	19,069 Added 1501.5%	20,339 $1.21 Million
Q3 2017 Nov 07, 2017	BUY	$37.91 - $46.8 $48,145 - $59,436	1,270	1,270 $59,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $127M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Enanta Pharmaceuticals Inc Transaction History